Allergic bronchopulmonary mycosis associated with Talaromyces boninensis: A case report.

J Infect ChemotherOct 9, 2026 (epub)
Case ReportPulmonologyAllergy & ImmunologyInfectious DiseasesPathology (Anatomic & Clinical)

Yasutaka Hirasawa, Katsuhiko Kamei, Akira Watanabe et al.

✦ AI-curated · Sources linked

Case in brief

A patient was evaluated for allergic bronchopulmonary mycosis (ABPM), an airway hypersensitivity disorder that can be caused by fungi other than Aspergillus. The patient met the diagnostic criteria proposed by the Japan ABPM Research Program. Talaromyces boninensis was isolated from bronchial lavage fluid and identified by molecular analysis, supporting its association with the ABPM diagnosis. The abstract does not report the patient’s symptoms, treatment, or clinical outcome.

What made this case unusual

The case associated ABPM with T. boninensis, a non-Aspergillus fungus; the authors describe it as the first such case to their knowledge.

Diagnostic / clinical pearl

In suspected ABPM, consider fungi beyond Aspergillus; bronchial lavage isolation with molecular identification can help establish the implicated organism.

Source

PubMed · PMID 42854869

Published in J Infect Chemother. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pulmonology

Clinical ResearchOncology (Medical)

Curative-intent management of de novo metastatic nasopharyngeal carcinoma: an evidence-based consensus guideline from the International Collaborating Oncology Organisations.

This international consensus guideline addresses curative-intent management of de novo metastatic nasopharyngeal carcinoma, a population historically treated with palliative intent.

Lancet OncolOct 29, 2026Read summary
Clinical ResearchHematology

Decitabine plus busulfan-cyclophosphamide versus busulfan-cyclophosphamide myeloablative conditioning before allogeneic haematopoietic stem cell transplantation for reducing risk of relapse in adult KMT2A‑rearranged leukaemia in China: an open-label, multicentre, randomised phase 3 trial.

This open-label, multicentre, randomised phase 3 trial compared decitabine plus busulfan-cyclophosphamide (DAC-BuCy) with BuCy conditioning before allogeneic HSCT in 130 patients aged 14–65 years with KMT2A-rearranged…

Lancet HaematolOct 30, 2026Read summary
Clinical ResearchPediatrics

Prone positioning and high-frequency oscillatory ventilation in early paediatric acute respiratory distress syndrome (PROSpect): an international, two-by-two factorial, response-adaptive, phase 3, randomised controlled trial.

PROSpect was an international, two-by-two factorial, phase 3 randomised controlled trial comparing prone with supine positioning and high-frequency oscillatory ventilation (HFOV) with conventional mechanical ventilation…

LancetOct 30, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.